Central nervous system (CNS) exposure of next generation quinoline methanols is reduced relative to mefloquine after intravenous (IV) dosing in mice

Geoffrey S. Dow, Erin Milner, Diana Caridha, Sean Gardner, Charlotte Lanteri, Michael Kozar, Ann Mannila, William McCalmont, Victor Melendez, Jay Moon, Kevin Read, Suzanne Norval, Norma Roncal, David Shackleford, Jason Sousa, Jessica Stouten, Karen White, Qiang Zeng, Susan Charman

    Research output: Contribution to conferenceAbstract

    Original languageEnglish
    Pages213-213
    Number of pages1
    Publication statusPublished - Nov 2010

    Cite this

    Dow, G. S., Milner, E., Caridha, D., Gardner, S., Lanteri, C., Kozar, M., Mannila, A., McCalmont, W., Melendez, V., Moon, J., Read, K., Norval, S., Roncal, N., Shackleford, D., Sousa, J., Stouten, J., White, K., Zeng, Q., & Charman, S. (2010). Central nervous system (CNS) exposure of next generation quinoline methanols is reduced relative to mefloquine after intravenous (IV) dosing in mice. 213-213. http://www.ajtmh.org/content/83/5_Suppl/211.full.pdf+html